Eli Lilly is set to invest at least $27 billion in building four new manufacturing plants in the United States over the next five years, with an expectation of creating more than 3,000 skilled jobs and 10,000 construction jobs. This investment follows recent discussions between US President Trump and drug company executives regarding concerns over potential tariffs on drug imports. Eli Lilly's CEO emphasized the importance of tax reforms introduced in Trump's first term in supporting domestic manufacturing initiatives. Further details regarding the sites for the new plants are expected to be announced later this year.
Eli Lilly will invest $27bn to establish four new US manufacturing plants, potentially generating 3,000 skilled jobs and 10,000 construction positions, bolstering domestic production.
The establishment of new plants underscores a proactive response to possible drug import tariffs, highlighting Eli Lilly’s commitment to domestic manufacturing amid regulatory concerns.
Collection
[
|
...
]